Many studies have proposed that obese patients have a greater risk of developing NAFLD (75%–100%) than the general population because their higher serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) concentrations reflect liver injury caused by hepatic steatosis [26]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.